Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study on the Efficacy and Functional Recovery of Switching From Oral Antipsychotics to Paliperidone Palmitate Injection in the Treatment of Schizophrenia

NCT07075237 is registered in ClinicalTrials.gov with Jiangsu Province Nanjing Brain Hospital as lead sponsor.

NCT NCT07075237
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07075237 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study on the Efficacy and Functional Recovery of Switching From Oral Antipsychotics to Paliperidone Palmitate Injection in the Treatment of Schizophrenia
Lead sponsor
Jiangsu Province Nanjing Brain Hospital
Phase
Phase 4
Overall status
Not yet recruiting
Start date
October 31, 2025
Completion date
March 31, 2027
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia